Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
From MaRDI portal
Publication:6625629
DOI10.1002/SIM.8097zbMATH Open1545.62564MaRDI QIDQ6625629
W. Katherine Yih, Philipe Dias, Wilson M. Lopes, Ivair Silva
Publication date: 28 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
- Statistical approaches to interim monitoring of medical trials: A review and commentary
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Design and analysis of group sequential tests based on the type I error spending rate function
- Sequential Tests of Statistical Hypotheses
Related Items (2)
A seasonality-adjusted sequential test for vaccine safety surveillance ⋮ Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data
This page was built for publication: Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6625629)